Royalty Pharma closes $1.5B senior notes offering across three tranches

Royalty Pharma plc

Issued $500M 5.150% notes due 2029, $500M 5.400% notes due 2034, $500M 5.900% notes due 2054.
Interest payable semiannually on March 2 and September 2, starting March 2025.
Notes are senior unsecured guaranteed by Royalty Pharma Holdings Ltd.
Issuer may redeem notes at specified prices; change-of-control repurchase provisions apply.
Offering closed June 10, 2024; aggregate principal $1.5B.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.